Elsevier

Brain Research

Volume 792, Issue 2, 11 May 1998, Pages 253-262
Brain Research

Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice

https://doi.org/10.1016/S0006-8993(98)00146-2Get rights and content

Abstract

Mouse purified striatal synaptosomes were used to study the release of newly synthesised [3H]-dopamine ([3H]-DA) or of previously taken up [3H]-DA. Quinpirole (QP, 10 μM), a D2/D3 dopaminergic agonist, was found to reduce the release of newly synthesised [3H]-DA with a larger amplitude when 4-aminopyridine (100 μM) instead than veratridine (1 μM) or potassium (25 mM) was used to evoke DA release. Among the different D2/D3 dopaminergic agonists tested R(−)-propylnorapomorphine (NPA) and quinpirole were the most potent. These compounds reduced, in a concentration-dependent manner, the 4-aminopyridine-evoked release of [3H]-DA previously taken up by synaptosomes (50% maximal inhibition). In contrast, the D3 agonist PD-128,907 had little effect even when used at 100 nM. The QP (100 nM)-induced response was completely antagonised by sulpiride (1 μM). Strikingly, the NPA (100 nM) and PD-128,907 (100 nM)-evoked responses were completely suppressed in D2 receptor-deficient mice. This data strongly suggest that only D2 but not D3 receptors are involved in the autoreceptor-mediated inhibition of the evoked release of [3H]-DA. Interestingly, while amphetamine-induced release of [3H]-DA was not modified, a slight reduction of [3H]-DA efflux induced by the dopamine (DA) uptake inhibitor cocaine was observed in D2 receptor-deficient mice.

Introduction

Dopamine acts through the binding to five distinct dopaminergic receptors (DR). These receptors have been classified in two families, D1R and D2R, upon pharmacological, biochemical and structural criteria. The D1R family comprises the D1R and D5R, while the D2R contains the D2R, D3R and D4R. The D2R is particular in that it exists in two molecular distinct species: D2S (short) and D2L (long). Both are generated from the same gene by differential splicing. D2L contains an additional insert of 29 amino-acids in the third cytoplasmic loop as related to D2S 41, 55. In spite of the numerous available dopaminergic agonists and antagonists within each dopaminergic receptor sub-family, highly specific drugs for each type of receptors are still lacking [55]. This has limited the precise determination by pharmacological studies, of the functional characteristics of the different types of receptors. Genetically modified mice lacking components of the dopaminergic transmission have been generated by homologous recombination. The study of these animals has greatly enhanced our understanding of the physiological function of the different receptors in vivo. Indeed, D1R, D2R, D3R and D4R-deficient mice have been generated. Interestingly, these animals present specific phenotypes which have given insights into the specific function of each receptor 1, 6, 10, 22, 29, 34, 37, 38, 39, 43, 46, 60.

We analysed D2R-deficient mice 6, 10, 34, 37, 48in order to confirm the role of D2Rs as autoreceptors and to look for an eventual role of the D3R in this process in the absence of D2R. Indeed, in transfected cells both D2Rs and D3Rs have been reported to act as autoreceptors [57]. As for dopamine, most D2 agonists used in release studies to investigate the properties of dopaminergic autoreceptors, were found to have higher affinity for D3R than for D2R [55]. In addition, controversies exist concerning the presence of D3R in nigral dopaminergic neurones and the existence of species differences 4, 8, 17, 19, 20, 40, 54. No significant difference in the pattern of expression of the D3R and D4R genes was found in D2R-deficient mice. Furthermore, the number and affinity of the D1Rs are not affected [6]. Recent studies using these mice have shown a very weak but specific residual [125I]-iodosulpride labelling in the substantia nigra–ventrotegmental area of D2R-deficient mice. From this study, it was concluded that D2Rs and D3Rs share a common presynaptic localisation in dopaminergic neurones, although D2Rs are the most abundant [37]. In this article, we confirm the previously obtained results and we show that both NPA (100 nM) and PD-128,907 (100 nM) (a D3 specific agonist)-evoked responses were completely suppressed in D2R-deficient mice.

Section snippets

Materials

Initial experiments were performed on male C57BL/6 mice from Charles River (France). Animals were housed in a temperature-controlled room (22–23°C) in which the light was on from 0600–2000 h. Mice lacking D2R (−/−) [6]and respective control littermates (+/+) were obtained by matings of heterozygous mice. All experiments were conducted in conformity with the French publication on animal experimentation (no. 87-848), the U.K. Animals (Scientific Procedures) Act (1986) and the European Communities

Quinpirole-induced inhibition of dopamine release under different conditions of depolarisation

Initial experiments were performed with striatal synaptosomes from C57BL/6 mice by measuring the release of [3H]-DA continuously synthesised from [3H]-tyrosine. The three depolarising agents, potassium chloride (25 mM), veratridine (1 μM) and 4-AP (100 μM) which act through different processes were selected to evoke the release of newly synthesised [3H]-DA. As illustrated in Fig. 1, at the respective concentrations used, these agents stimulated the release of [3H]-DA with a similar amplitude.

Discussion

Compelling evidence indicates that in the striatum, D2Rs are located on populations of striatal cells and on terminals of the corticostriatal projections 15, 16, 27, 28, 32, 33, 50, 53. D2Rs are also present on synaptic terminals, soma and dendrites of the nigrostriatal dopaminergic neurones 2, 5, 27, 28, 35, 44, 53. It was originally thought that an inhibitory control of DA synthesis was responsible for the decreased release of the transmitter. Indeed, on the basis of experiments performed on

Acknowledgements

A.C. is a research fellow of Rhône-Poulenc Rorer. This study was supported by INSERM, Collège de France and Rhône-Poulenc Rorer.

References (60)

  • P.R. Dunkley et al.

    A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions

    Brain Res.

    (1988)
  • M. Fillenz

    Short-term control of transmitter synthesis in central catecholaminergic neurones

    Prog. Biophys. Mol. Biol.

    (1993)
  • F.M. Filloux et al.

    Dopamine D2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride

    Eur. J. Pharmacol.

    (1987)
  • R.R. Gainetdinov et al.

    Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats

    Eur. J. Pharmacol.

    (1994)
  • Y. Kawaguchi et al.

    Striatal interneurones: chemical, physiological and morphological characterization

    TINS

    (1995)
  • C. Le Moine et al.

    Rat striatal and mesencephalic neurons contain the long isoform of the D2 dopamine receptor mRNA

    Brain Res. Mol. Brain Res.

    (1991)
  • E. Meller et al.

    Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors

    Eur. J. Pharmacol.

    (1993)
  • P. Onali et al.

    Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes

    Brain Res.

    (1988)
  • A. Saiardi et al.

    The physiological role of dopamine D2 receptors

    Adv. Pharmacol.

    (1997)
  • B. Scatton

    Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission

    Life Sci.

    (1982)
  • P. Sokoloff et al.

    Novel dopamine receptors half a decade later

    TIPS

    (1995)
  • M. Titeler et al.

    Selective labelling of different dopamine receptors by a new agonist [3H]-ligand: [3H]-N-propylnorapomorphine

    Eur. J. Pharmacol.

    (1979)
  • M. Xu et al.

    Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses

    Cell

    (1994)
  • D. Accili et al.

    A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

    Proc. Natl. Acad. Sci. U.S.A.

    (1996)
  • G.K. Aghajanian et al.

    Dopamine `autoreceptors': pharmacological characterization by microiontophoretic single cell recording studies

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1977)
  • C.W. Aretha et al.

    Dopamine D3-preferring ligands act at synthesis modulating autoreceptors

    J. Pharmacol. Exp. Ther.

    (1995)
  • J.H. Baik et al.

    Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

    Nature

    (1995)
  • J.F. Bowyer et al.

    Modulation of the Ca++-evoked release of [3H]-dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists

    J. Pharmacol. Exp. Ther.

    (1987)
  • P. Calabresi et al.

    Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors

    J. Neurosci.

    (1997)
  • W.A. Cass et al.

    Inhibition of striatal dopamine release by the selective D2 dopamine receptor agonist N-0437 is blocked by quinine

    Synapse

    (1990)
  • Cited by (0)

    View full text